Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Joseph G Akar
Research Area(s) / Expertise:

Atrial Fibrillation

Electrophysiology & Arrhythmia

Atrial Arrhythmias
Personal History Dr Joseph Gabriel Akar was born in January 1971 and speaks Arabic, English and French.9 He is an Associate Professor of Medicine in the Section of Cardiology at the Yale University School of Medicine. He is currently Chief of Cardiac Electrophysiology and Director of the Electrophysiology Laboratory and the Complex Ablation Program at Yale-New Haven Hospital. … View more
Jeroen J Bax
Job title: Director, Echo Laboratory & Non-invasive Imaging, Department of Cardiology
Personal History Dr Jeroen Joost Bax was born in Amsterdam and was the first member of his family to study medicine. As a professor, Dr Bax has mentored over 60 international PhD students in his cardiac imaging research centre at Leiden University Medical Center (LUMC) and his students have achieved prominent positions at medical institutions throughout the world.1 “I care a lot about the… View more
ADA 24: FLOW Trial: Kidney Outcomes in Patients Treated with Semaglutide
Author(s): Vlado Perkovic Added: 1 year ago
ADA 24 - In this succinct video, we are joined by Dr Vlado Perkovic (UNSW Sydney, Kensington, AU) to discuss a trial investigating the use of semaglutide in patients with type 2 diabetes and chronic kidney disease (NCT03819153).The FLOW trial enrolled 3533 participants with type 2 diabetes and chronic kidney disease, who were then randomized to recieve either semaglutide or placebo. The median… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Olezarsen Cuts Triglycerides and Pancreatitis Risk
Added: 5 months ago Source:  Radcliffe CVRM
For patients with severe hypertriglyceridemia, monthly treatment with olezarsen significantly reduced triglyceride levels and the incidence of acute pancreatitis compared with placebo, according to findings from two pivotal trials, CORE-TIMI 72a and CORE2-TIMI 72b.¹Olezarsen is an antisense oligonucleotide designed to inhibit the production of apolipoprotein C-III (ApoC-III), a key protein in the… View more

Cardiovascular Kidney Metabolic

Prevention & Chronic Conditions
Jaan Eha

Author